Published in J Immunol on September 01, 1997
Dendritic cells acquire the MAGE-3 human tumor antigen from apoptotic cells and induce a class I-restricted T cell response. Proc Natl Acad Sci U S A (2000) 1.33
beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma. J Clin Invest (1998) 1.17
Expression of MAGE-1 and -3 genes and gene products in human hepatocellular carcinoma. Br J Cancer (1999) 0.91
Cytotoxic and regulatory properties of circulating Vδ1+ γδ T cells: a new player on the cell therapy field? Mol Ther (2014) 0.90
Induction of MAGE-A3 and HPV-16 immunity by Trojan vaccines in patients with head and neck carcinoma. Head Neck (2012) 0.88
Although divergent in residues of the peptide binding site, conserved chimpanzee Patr-AL and polymorphic human HLA-A*02 have overlapping peptide-binding repertoires. J Immunol (2011) 0.84
Identification of an HLA-A2-restricted epitope peptide derived from hypoxia-inducible protein 2 (HIG2). PLoS One (2014) 0.79
Identification and functional perspective of a novel HLA-A allele: A*0279. Immunogenetics (2006) 0.76
A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (1991) 14.57
Tumor antigens recognized by T lymphocytes. Annu Rev Immunol (1994) 6.16
A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med (1994) 5.03
HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science (1997) 4.58
Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med (1994) 4.20
Human tumor antigens recognized by T lymphocytes. J Exp Med (1996) 3.63
Type 1 T regulatory cells. Immunol Rev (2001) 3.26
Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int J Cancer (1999) 3.19
BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity (1995) 3.13
Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics (1994) 2.93
A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J Exp Med (1992) 2.92
T cell defined tumor antigens. Curr Opin Immunol (1997) 2.90
Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics (1992) 2.45
Differentiation of T regulatory cells by immature dendritic cells. J Exp Med (2001) 2.35
Direct isolation, phenotyping and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood. Curr Biol (1998) 2.21
Rexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2'-deoxycytidine treatment. Int J Cancer (2001) 2.07
A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur J Immunol (1994) 1.83
Presence on a human melanoma of multiple antigens recognized by autologous CTL. Int J Cancer (1989) 1.80
Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4(+) T lymphocytes. J Exp Med (1999) 1.67
Identification of the MAGE-1 gene product by monoclonal and polyclonal antibodies. Proc Natl Acad Sci U S A (1994) 1.61
Safety of retroviral gene marking with a truncated NGF receptor. Nat Med (2003) 1.60
Expression of human adenosine deaminase in nonhuman primates after retrovirus-mediated gene transfer. J Exp Med (1987) 1.57
Properties of the DNA-delay mutants of bacteriophage T4. Virology (1971) 1.49
Reversal of diabetes in mice by implantation of human fibroblasts genetically engineered to release mature human insulin. Hum Gene Ther (1999) 1.48
A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma. J Exp Med (1997) 1.47
In vivo gene therapy of metachromatic leukodystrophy by lentiviral vectors: correction of neuropathology and protection against learning impairments in affected mice. Nat Med (2001) 1.46
Structural and functional features of the alpha 3 chain indicate a bridging role for chicken collagen VI in connective tissues. Biochemistry (1990) 1.45
Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer. Blood (1994) 1.45
Risk of pocket hematoma in patients on chronic anticoagulation with warfarin undergoing electrophysiological device implantation: a comparison of different peri-operative management strategies. Eur Rev Med Pharmacol Sci (2015) 1.42
Ancient vs. recent processes as factors shaping the genetic variation of the European wild boar: are the effects of the last glaciation still detectable? Mol Ecol (2008) 1.40
Tungsten oxide nanowires grown on amorphous-like tungsten films. Nanotechnology (2015) 1.38
Characterization of the GAGE genes that are expressed in various human cancers and in normal testis. Cancer Res (1999) 1.38
Genes coding for tumor antigens recognized by cytolytic T lymphocytes. Immunol Rev (1995) 1.38
Herpes simplex virus thymidine kinase gene transfer for controlled graft-versus-host disease and graft-versus-leukemia: clinical follow-up and improved new vectors. Hum Gene Ther (1998) 1.34
Dendritic cells acquire the MAGE-3 human tumor antigen from apoptotic cells and induce a class I-restricted T cell response. Proc Natl Acad Sci U S A (2000) 1.33
Patients younger than 40 years with gastric carcinoma: Helicobacter pylori genotype and associated gastritis phenotype. Cancer (1999) 1.31
Hierarchical TiO2 photoanode for dye-sensitized solar cells. Nano Lett (2010) 1.30
Chemotactic activity of recombinant human granulocyte colony-stimulating factor. Blood (1988) 1.30
Expression of CXCR4, the receptor for stromal cell-derived factor-1 on fetal and adult human lympho-hematopoietic progenitors. Eur J Immunol (1999) 1.29
Human CD34(+) cells express CXCR4 and its ligand stromal cell-derived factor-1. Implications for infection by T-cell tropic human immunodeficiency virus. Blood (1999) 1.27
Genetic diversity within and between European pig breeds using microsatellite markers. Anim Genet (2006) 1.26
Cytotoxic T-lymphocyte clones from different patients display limited T-cell-receptor variable-region gene usage in HLA-A2-restricted recognition of the melanoma antigen Melan-A/MART-1. Proc Natl Acad Sci U S A (1995) 1.24
A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease. Blood (2001) 1.23
Transfer of the HSV-tk gene into donor peripheral blood lymphocytes for in vivo modulation of donor anti-tumor immunity after allogeneic bone marrow transplantation. Hum Gene Ther (1995) 1.20
An in vivo model of somatic cell gene therapy for human severe combined immunodeficiency. Science (1991) 1.19
Characterization of natural peptide ligands for HLA-B*4402 and -B*4403: implications for peptide involvement in allorecognition of a single amino acid change in the HLA-B44 heavy chain. Tissue Antigens (1994) 1.19
Sequence and expression pattern of the human MAGE2 gene. Immunogenetics (1994) 1.16
Effect of topical ketanserin administration on intraocular pressure. Br J Ophthalmol (1993) 1.15
Quantitative trait loci affecting milk yield and protein percentage in a three-country Brown Swiss population. J Dairy Sci (2008) 1.14
A MAGE-A3 peptide presented by HLA-DP4 is recognized on tumor cells by CD4+ cytolytic T lymphocytes. Cancer Res (2000) 1.12
Clinical indications for cardiac computed tomography. From the Working Group of the Cardiac Radiology Section of the Italian Society of Medical Radiology (SIRM). Radiol Med (2012) 1.12
Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1. J Immunol (1999) 1.11
Stimulation of CD40 on immunogenic human malignant melanomas augments their cytotoxic T lymphocyte-mediated lysis and induces apoptosis. Cancer Res (1999) 1.10
Comparison of prenatal muscle tissue expression profiles of two pig breeds differing in muscle characteristics. J Anim Sci (2006) 1.09
A first comparative map of copy number variations in the sheep genome. Genomics (2010) 1.06
Natural cytotoxicity on tumour cells of human macrophages obtained from diverse anatomical sites. Clin Exp Immunol (1980) 1.06
Inhibition of natural killer activity by human bronchoalveolar macrophages. J Immunol (1982) 1.05
Electroporation of immature and mature dendritic cells: implications for dendritic cell-based vaccines. Gene Ther (2005) 1.05
Copy number variation and missense mutations of the agouti signaling protein (ASIP) gene in goat breeds with different coat colors. Cytogenet Genome Res (2009) 1.05
Estimation of the frequencies of anti-MAGE-3 cytolytic T-lymphocyte precursors in blood from individuals without cancer. Int J Cancer (1998) 1.03
Phase Ib study of NGR-hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours. Br J Cancer (2009) 1.03
Hierarchically organized nanostructured TiO2 for photocatalysis applications. Nanotechnology (2008) 1.02
The tumor protein MAGE-1 is located in the cytosol of human melanoma cells. Biochem Biophys Res Commun (1994) 1.01
MAGE-1 expression threshold for the lysis of melanoma cell lines by a specific cytotoxic T lymphocyte. Melanoma Res (1997) 1.01
Nuclear inheritance of resistance to antimycin A in Saccharomyces cerevisiae. Mol Gen Genet (1979) 1.00
Modulation of GvHD by suicide-gene transduced donor T lymphocytes: clinical applications in mismatched transplantation. Cytotherapy (2005) 1.00
MAGE BAGE and GAGE genes expression in fresh epithelial ovarian carcinomas. Int J Cancer (1996) 1.00
The porcine fat mass and obesity associated (FTO) gene is associated with fat deposition in Italian Duroc pigs. Anim Genet (2008) 0.99
Hematopoietic histoincompatibility reactions by NK cells in vitro: model for genetic resistance to marrow grafts. Science (1985) 0.99
Optimal management of traumatic aortic injury. Eur J Vasc Endovasc Surg (2008) 0.99
Identification of tumour rejection antigens recognized by T lymphocytes. Cancer Surv (1992) 0.98
Comparison between cationic polymers and lipids in mediating systemic gene delivery to the lungs. Gene Ther (1999) 0.97
Alpha 1 chain of chick type VI collagen. The complete cDNA sequence reveals a hybrid molecule made of one short collagen and three von Willebrand factor type A-like domains. J Biol Chem (1989) 0.97
Acquisition of intact allogeneic human leukocyte antigen molecules by human dendritic cells. Blood (2000) 0.97
Isolation, characterization, and in vitro differentiation of ovine amniotic stem cells. Vet Res Commun (2010) 0.96
Bovine papillomavirus E5 oncoprotein binds to the activated form of the platelet-derived growth factor beta receptor in naturally occurring bovine urinary bladder tumours. Oncogene (2006) 0.96
Extremely low frequency electromagnetic field exposure affects fertilization outcome in swine animal model. Theriogenology (2010) 0.95